Dynavax Announces Second Quarter 2021 Financial Results

EMERYVILLE, Calif.: EMERYVILLE, Calif., Aug. 4, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the second quarter of 2021. "Our successful execution in the second quarter of 2021 continued to build on the progress made...

Click to view original post